The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a serious threat to public health and prompted researchers to find anti-coronavirus 2019 (COVID-19) compounds. In this study, the long short-term memory-based recurrent neural network was used to generate new inhibitors for the coronavirus. First, the model was trained to generate drug compounds in the form of valid simplified molecular-input line-entry system strings. Then, the structures of COVID-19 main protease inhibitors were applied to fine-tune the model. After fine-tuning, the network could generate new molecular structures as novel SARS-CoV-2 main protease inhibitors. Molecular docking exhibited that some generated compounds have the proper affinity to the active site of the protease. Molecular Dynamics simulations explored binding free energies of the compounds over simulation trajectories. In addition, in silico absorption, distribution, metabolism, and excretion studies showed that some novel compounds could be formulated as orally active agents. Based on molecular docking and molecular dynamics simulation studies, compound AADH possessed significant binding affinity and presumably inhibition against the SARS-CoV-2 main protease enzyme. Therefore, the proposed deep learning-based model was capable of generating promising anti-COVID-19 drugs.
Get full access to this article
View all access options for this article.
References
1.
BilodeauC, JinW, JaakkolaT, et al.Generative models for molecular discovery: Recent advances and challenges. Wiley Interdiscip Rev Comput Mol Sci, 2022; 12(5):e1608.
2.
BouzianeSE, KhadirMT. Towards an energy management system based on a multi-agent architecture and LSTM networks. J Exp Theor Artif Intell, 2022:1–19.
3.
CaseDA, BelfonK, Ben-ShalomIY, et al.AMBER 2020: University of California. San Francisco, USA; 2020.
4.
DainaA, MichielinO, ZoeteV. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep, 2017; 7(1):1–13.
5.
ErtlP, RohdeB, SelzerP. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem, 2000; 43(20):3714–3717.
6.
EshaghnezhadM, EffatiS, MansooriA. A compact MLCP-based projection recurrent neural network model to solve shortest path problem. J Exp Theor Artif Intell, 2023; 35(7):1101–1119.
7.
FriesnerRA, BanksJL, MurphyRB, et al.Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J Med Chem, 2004; 47(7):1739–1749.
8.
GaultonA, HerseyA, NowotkaM, et al.The ChEMBL Database in 2017. Nucleic Acids Res, 2017; 45(D1):D945–D954.
9.
GhoseAK, ViswanadhanVN, WendoloskiJJ. Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods. J Phys Chem A, 1998; 102(21):3762–3772.
10.
GohlkeH, KielC, CaseDA. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS Complexes. J Mol Biol, 2003; 330(4):891–913; doi: 10.1016/s0022-2836(03)00610-7.
11.
GuptaA, MüllerAT, HuismanBJH, et al.Generative recurrent networks for de novo drug design. Mol Inform, 2018; 37(1–2):1700111.
12.
HarderE, DammW, MapleJ, et al.OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput, 2016; 12(1):281–296.
13.
HarrachMF, DrosselB. Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. J Chem Phys, 2014; 140(17):174501.
14.
HarveyMJ, De FabritiisG. An Implementation of the Smooth Particle Mesh Ewald Method on GPU Hardware. J Chem Theory Comput, 2009; 5(9):2371–2377.
15.
HochreiterS, Urgen SchmidhuberJ¨. Long Short-Term Memory. n.d.
16.
JinZ, DuX, XuY, et al.Structure of Mpro from SARS-CoV-2 and Discovery of Its Inhibitors. Nature, 2020; 582(7811):289–293.
17.
KaradeD, KaradeV.AIDrugApp: Artificial Intelligence-Based Web-App for Virtual Screening of Inhibitors against SARS-COV-2. J Exp Theor Artif Intell, 2022:1–49.
18.
LipinskiCA, LombardoF, DominyBW, FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 2001; 46(1–3):3.
19.
Madhavi SastryG, AdzhigireyM, DayT, et al.Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des, 2013; 27(3):221–234.
20.
MukherjeeS, GhoshM, BasuchowdhuriP.DeepGLSTM: Deep Graph Convolutional Network and LSTM Based Approach for Predicting Drug-Target Binding Affinity. In: Proceedings of the 2022 SIAM International Conference on Data Mining (SDM) SIAM; 2022; pp. 729–737.
21.
OlivecronaM, BlaschkeT, EngkvistO, et al.Molecular de-novo design through deep reinforcement learning. J Cheminform, 2017; 9(1):1–14.
22.
OnufrievA, BashfordD, CaseDA. Modification of the generalized born model suitable for macromolecules. J Phys Chem B, 2000; 104(15):3712–3720; doi: 10.1021/jp994072s.
23.
PascanuR, MikolovT, BengioY.On the Difficulty of Training Recurrent Neural Networks. In: International Conference on Machine Learning PMLR; 2013; pp. 1310–1318.
24.
PolykovskiyD, ZhebrakA, Sanchez-LengelingB, et al.Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models. Front Pharmacol, 2020:11.
25.
RajnikM, CascellaM, CuomoA, et al.Features, Evaluation, and Treatment of Coronavirus (COVID-19). Uniformed Services University of The Health Sciences; 2021.
26.
RoeDR.Cheatham 3rd TE. PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput, 2013; 9:3084–3095.
27.
RyckaertJ-P, CiccottiG, BerendsenHJC. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes. J Comput Phys, 1977; 23(3):327–341.
28.
Salomon-FerrerR, CaseDA, WalkerRC. An Overview of the Amber Biomolecular Simulation Package. Wiley Interdiscip Rev Comput Mol Sci, 2013a;3(2):198–210.
29.
Salomon-FerrerR, GotzAW, PooleD, et al.Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald. J Chem Theory Comput, 2013b;9(9):3878–3888.
30.
SeglerMHS, KogejT, TyrchanC, et al.Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks. ACS Cent Sci, 2018; 4(1):120–131.
31.
ShiT, HuangS, ChenL, et al.A Molecular Generative Model of ADAM10 Inhibitors by Using GRU-Based Deep Neural Network and Transfer Learning. Chemom Intell Lab Syst, 2020; 205:104122.
32.
SrinivasanJ, CheathamTE, CieplakP, et al.Continuum Solvent Studies of the Stability of DNA, RNA, and Phosphoramidate-DNA Helices. J Am Chem Soc, 1998; 120(37):9401–9409; doi: 10.1021/ja981844+.
SubakanYC, SmaragdisP. Diagonal Rnns in Symbolic Music Modeling. In: 2017 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA) IEEE; 2017; pp. 354–358.
35.
TianC, KasavajhalaK, BelfonKAA, et al.Ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution. J Chem Theory Comput, 2019; 16(1):528–552.
36.
TianD, LiuY, LiangC, et al.An Update Review of Emerging Small-Molecule Therapeutic Options for COVID-19. Biomed Pharmacother, 2021:111313.
37.
Veliz-CubaA, ShouvalHZ, JosićK, et al.Networks that learn the precise timing of event sequences. J Comput Neurosci, 2015; 39(3):235–254.
38.
WangE, SunH, WangJ, et al.End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chem Rev, 2019; 119(16):9478–9508; doi: 10.1021/acs.chemrev.9b00055.
39.
WangM, WangZ, SunH, et al.Deep learning approaches for de novo drug design: An overview. Curr Opin Struct Biol, 2022; 72:135–144.
40.
WangWR, WolfRJ, CaldwellJW, et al.Development and testing of a general amber force field. J Comput Chem, 2004; 25(9):1157–1174.
41.
WeiserJ, ShenkinPS, StillWC. Approximate Atomic Surfaces from Linear Combinations of Pairwise Overlaps (LCPO). J Comput Chem, 1999; 20(2):217–230; doi: 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A.
42.
WuY, SchusterM, ChenZ, et al.Google's Neural Machine Translation System: Bridging the Gap between Human and Machine Translation. arXiv Prepr arXiv160908144 2016.
43.
YuanW, JiangD, NambiarDK, et al.Chemical Space Mimicry for Drug Discovery. J Chem Inf Model, 2017; 57(4):875–882.
44.
ZhangL, LinD, SunX, et al.Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved α-Ketoamide Inhibitors. Science (80-), 2020; 368(6489):409–412.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
